Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.

Scheinberg A, O'Flaherty S, Waugh MC, Baxter A, Gurd K.

J Paediatr Child Health. 2008 Jul-Aug;44(7-8):468-9; author reply 469. doi: 10.1111/j.1440-1754.2008.01349.x. No abstract available.

PMID:
18638338
2.

Botulinum neurotoxin A: an unusual systemic effect.

Howell K, Selber P, Graham HK, Reddihough D.

J Paediatr Child Health. 2007 Jun;43(6):499-501.

PMID:
17535186
3.

Botulinum toxin A injection for children with spastic cerebral palsy.

YaJie W, BaoQin G.

Dev Med Child Neurol. 2008 Aug;50(8):640. doi: 10.1111/j.1469-8749.2008.03023.x. No abstract available.

4.

[Botulinum toxin treatment of spastic cerebral palsy].

Hansen LK, Pedersen NR, Westphall IT, Pedersen LT, Jensen H, Villads A.

Ugeskr Laeger. 2004 Aug 16;166(34):2888-90. Danish. No abstract available.

PMID:
15449526
5.

[High doses of botulinum toxin type A in children: efficacy and safety in clinical practice].

Filipetti P, Chantraine F.

Ann Readapt Med Phys. 2007 Jan;50 Suppl 1:S7-S11. Review. French.

PMID:
17550812
6.

Re: Botulinum toxin for the treatment of facial flushing.

Kranendonk SK, Ferris LK, Obagi S.

Dermatol Surg. 2005 Apr;31(4):491; author reply 492. No abstract available.

PMID:
15871333
7.

[Treatment of drooling with botulinum toxin type A in cerebral palsy].

Duarte CS, Alves TR, Azeredo PM, Almeida SI.

Rev Neurol. 2009 Dec 1-15;49(11):610. Spanish. No abstract available.

8.

Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.

Crowner BE, Racette BA.

Pediatr Neurol. 2008 Oct;39(4):253-8. doi: 10.1016/j.pediatrneurol.2008.07.003.

PMID:
18805363
9.
10.

How doctors think--and treat with botulinum toxin.

Schroeder AS, Koerte I, Berweck S, Ertl-Wagner B, Heinen F.

Dev Med Child Neurol. 2010 Sep;52(9):875-6. doi: 10.1111/j.1469-8749.2010.03692.x. Epub 2010 May 10. No abstract available.

11.

Treatment of juvenile spasticity with botulinum toxin type A.

Desloovere K, Molenaers G.

Nervenarzt. 2008 Jun;79 Suppl 1:19-21. Review. No abstract available.

PMID:
18927960
12.

Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.

Ruiz FJ, Guest JF, Lehmann A, Davie AM, Güttler K, Schlüter O, Dreiss G.

Eur J Health Econ. 2004 Oct;5(3):227-35.

PMID:
15714343
13.

Does botulinum toxin prevent or promote deformity in children with cerebral palsy?

Gough M.

Dev Med Child Neurol. 2009 Feb;51(2):89-90. doi: 10.1111/j.1469-8749.2008.03247.x. No abstract available.

14.

[Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].

Molenaers G, Desloovere K, De Cat J.

Orthopade. 2004 Oct;33(10):1119-28. German.

PMID:
15278274
15.

Why do children with cerebral palsy discontinue therapy with botulinum toxin A?

Weigl DM, Arbel N.

Dev Med Child Neurol. 2007 Feb;49(2):159-60. No abstract available.

PMID:
17297747
16.

[Botulinum toxin injections for facial rejuvenation].

Société Française de Chirurgie Plastique Reconstructrice et Esthétique..

Ann Chir Plast Esthet. 2004 Oct;49(5):553-6. French. No abstract available.

PMID:
15600009
17.

Botulinum toxin for cerebral palsy; where are we now?

Morton RE, Hankinson J, Nicholson J.

Arch Dis Child. 2004 Dec;89(12):1133-7. Review.

18.

Evaluation of a multimodal management of prematurity-related spasticity.

Papavasiliou AS, Rapidi CA, Filiopoulos C, Rizou C, Skouteli HN.

Pediatr Neurol. 2006 Dec;35(6):400-7.

PMID:
17138009
19.

'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.

Linder-Lucht M, Kirschner J, Herrmann J, Geth K, Korinthenberg R, Berweck S, Heinen F, Mall V.

Dev Med Child Neurol. 2006 Apr;48(4):319-20. No abstract available.

20.

Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.

Sriskandan N, Moody A, Howlett DC.

Br J Oral Maxillofac Surg. 2010 Jan;48(1):58-60. doi: 10.1016/j.bjoms.2009.03.005. Epub 2009 Apr 15.

PMID:
19371986

Supplemental Content

Support Center